Gentil et al. found that AHR is underexpressed in patients with chronic myeloid leukemia (CML), and activating AHR can effectively inhibit leukemia cell proliferation [20]. The gene discussed is AHR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.